FDA Grants Approval for Haloperidol ANDA214470 by Alembic
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 214470 for Haloperidol submitted by Alembic.
Asset / Drug
Drug and asset intelligence for Haloperidol with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.